Alibaba's AI advancements and promising financial growth make it a compelling stock with significant upside potential. Read ...

Eli Lilly (LLY) came out with quarterly earnings of $5.32 per share, beating the Zacks Consensus Estimate of $5.03 per share. This compares to earnings of $2.49 per share a year ago. These figures are ...

Michael Saylor's MicroStrategy (MSTR) rebranded to Strategy, with visuals pointing to a Bitcoin-centric company.

Eli Lilly (LLY) reports Q4 earnings Thursday. LLY stock up 8.22% YTD. Chart shows strong bullish momentum with potential for ...

Eli Lilly (LLY) stock rises as company posts Q4 2024 results, beating expectations with a twofold rise in revenue from weight ...

KBC Group NV raised its stake in shares of StepStone Group LP (NASDAQ:STEP – Free Report) by 64.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 3,032 ...

Holocene Advisors LP boosted its position in Microsoft Co. (NASDAQ:MSFT – Free Report) by 1,154.3% during the third quarter, ...

Booming sales of its blockbuster incretin-based weight loss and diabetes drugs Mounjaro and Zepbound powered Eli Lilly (LLY) to a 45% jump in ...

Eli Lilly And Co. (LLY) reported earnings for its fourth quarter that increased from last year and beat the Street estimates. The ...

Meta, Microsoft, and Google parent Alphabet are expecting a cumulative $228 billion in capital expenditures in 2025, driven ...

Eli Lilly stock rose after the drugmaker posted quarterly earnings that beat Wall Street expectations. Fourth-quarter adjusted earnings came in at $5.32 a share, above estimates of $5.01, according to ...